Gene · 1108
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Development in Biomedical Applications of Oligonucleotides with Triplex-Forming Ability. | Polymers (Basel) | 2023 | 36850142 | PubTator, text mining | PubMed |
| Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome. | Life (Basel) | 2023 | 36836887 | PubTator, text mining | PubMed |
| IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? | Int J Mol Sci | 2023 | 36834692 | PubTator, text mining | PubMed |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Cells | 2023 | 36831205 | PubTator, text mining | PubMed |
| ATP-Dependent Chromatin Remodellers in Inner Ear Development. | Cells | 2023 | 36831199 | PubTator, text mining | PubMed |
| Staphylococcus Infection: Relapsing Atopic Dermatitis and Microbial Restoration. | Antibiotics (Basel) | 2023 | 36830133 | PubTator, text mining | PubMed |
| Anti-MDA5-positive dermatomyositis and remission in a single referral centre population. | Clin Exp Rheumatol | 2023 | 36826791 | PubTator, text mining | PubMed |
| Identification of Chromatin Regulatory Factors Related to Immunity and Treatment of Alzheimer's Disease. | J Mol Neurosci | 2023 | 36826468 | PubTator, text mining | PubMed |
Bioinformatics based exploration of hsa-miR-194-5p regulation of CHD4 through PI3K/AKT signal pathway to enhance tumor resistance to apoptosis due to loss of nests and participate in poor prognosis of oral squamous cell carcinoma. | Ann Transl Med | 2023 | 36819582 | PubTator, text mining | PubMed |
| The future of sickle cell disease therapeutics rests in genomics. | Dis Model Mech | 2023 | 36815490 | PubTator, text mining | PubMed |
| Epigenetic regulation of plastin 3 expression by the macrosatellite DXZ4 and the transcriptional regulator CHD4. | Am J Hum Genet | 2023 | 36812914 | PubTator, text mining | PubMed |
| Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel. | Am J Clin Pathol | 2023 | 36812376 | PubTator, text mining | PubMed |
| A nucleolar long "non-coding" RNA encodes a novel protein that functions in response to stress. | Proc Natl Acad Sci U S A | 2023 | 36812203 | PubTator, text mining | PubMed |
| How I treat endocrine-dependent metastatic breast cancer. | ESMO Open | 2023 | 36806375 | PubTator, text mining | PubMed |
| Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. | Theranostics | 2023 | 36793866 | PubTator, text mining | PubMed |
| Primary maxillary sinus carcinosarcoma with multidisciplinary management: a case report with 4 years follow-up and literature review. | BMC Oral Health | 2023 | 36788533 | PubTator, text mining | PubMed |
| A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. | Rheumatol Int | 2023 | 36786873 | PubTator, text mining | PubMed |
| CHD1, a multifaceted epigenetic remodeler in prostate cancer. | Front Oncol | 2023 | 36776288 | PubTator, text mining | PubMed |
| BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. | Int J Mol Sci | 2023 | 36769189 | PubTator, text mining | PubMed |
Pentacyclic Triterpenoids-Based Ionic Compounds: Synthesis, Study of Structure-Antitumor Activity Relationship, Effects on Mitochondria and Activation of Signaling Pathways of Proliferation, Genome Reparation and Early Apoptosis. | Cancers (Basel) | 2023 | 36765714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1108/papers?page=18